Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting
International Journal of COPD2022Vol. Volume 17, pp. 2417–2429
Citations Over TimeTop 10% of 2022 papers
David Halpin, Kieran Rothnie, Victoria Banks, Alexandrosz Czira, Chris Compton, Robert Wood, Theo Tritton, Olivia Massey, R Wild, Neil G. Snowise, Kirill Nikitin, Raj Kumar Sharma, Afisi Ismaila, Claus Vogelmeier
Abstract
Patients with COPD in England initiating SITT had significantly better adherence and persistence compared with MITT initiators. These improvements continued at least 18 months following treatment initiation.
Related Papers
- → A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD(2016)254 cited
- → Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care(2018)13 cited
- → A review of current and developing fixed-dose LABA/LAMA combinations for treating COPD(2017)5 cited
- → P7‐39: Evaluation of the effect of ICS containing triple therapy with LAMA/LABA in comparison with LAMA/LABA in COPD patients(2021)
- → Faculty Opinions recommendation of Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD.(2019)